Picture of Xspray Pharma publ AB logo

XSPRAY Xspray Pharma publ AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: XSpray Pharma Changes Timeline For Dasynoc FDA Application Sumbission

Jan 8 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * CHANGES TIMELINE FOR SUMBISSION OF APPLICATION TO FDA FOR
DASYNOC
    * EXPECTS TO SUBMIT UPDATED APPLICATION IN MARCH/APRIL 2025

Source text:  ID:nMFN1DLssM 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Xspray Pharma publ AB

See all news